Joyce A. Gunter Riley

Array ( [id] => 19512369 [patent_doc_number] => 20240344055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => METHODS AND SYSTEMS FOR MODIFYING THE CRUMBS HOMOLOGUE-1 (CRB1) GENE [patent_app_type] => utility [patent_app_number] => 18/618660 [patent_app_country] => US [patent_app_date] => 2024-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19380934 [patent_doc_number] => 20240270804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => PROMOTER-ENHANCER SEQUENCES OF THE HUMAN TROPONIN T GENE FOR SELECTIVE EXPRESSION IN CARDIAC MYOCYTES [patent_app_type] => utility [patent_app_number] => 18/439546 [patent_app_country] => US [patent_app_date] => 2024-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18439546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19281858 [patent_doc_number] => 20240218332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => METHODS OF GENERATING MATURE HEPATOCYTES [patent_app_type] => utility [patent_app_number] => 18/386860 [patent_app_country] => US [patent_app_date] => 2023-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18386860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19297606 [patent_doc_number] => 20240226172 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2024-07-11 [patent_title] => MESENCHYMAL STEM CELL THERAPY OF EPILEPSY AND SEIZURE DISORDERS [patent_app_type] => utility [patent_app_number] => 18/493694 [patent_app_country] => US [patent_app_date] => 2023-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19297606 [patent_doc_number] => 20240226172 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2024-07-11 [patent_title] => MESENCHYMAL STEM CELL THERAPY OF EPILEPSY AND SEIZURE DISORDERS [patent_app_type] => utility [patent_app_number] => 18/493694 [patent_app_country] => US [patent_app_date] => 2023-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19111338 [patent_doc_number] => 20240123088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING [patent_app_type] => utility [patent_app_number] => 18/490443 [patent_app_country] => US [patent_app_date] => 2023-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19479436 [patent_doc_number] => 20240327478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS) [patent_app_type] => utility [patent_app_number] => 18/490611 [patent_app_country] => US [patent_app_date] => 2023-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19186356 [patent_doc_number] => 20240165269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS WITH BCL11A TRANSCRIPTION FACTOR EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/487740 [patent_app_country] => US [patent_app_date] => 2023-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18487740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19098088 [patent_doc_number] => 20240117316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHOD FOR PREPARING MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE, MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE PREPARED BY THE METHOD, AND USE OF MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE FOR REDUCING ADIPOGENESIS AND TREATING OSTEOARTHRITIS [patent_app_type] => utility [patent_app_number] => 18/376566 [patent_app_country] => US [patent_app_date] => 2023-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19049300 [patent_doc_number] => 20240091269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => TREATMENT OF BIPOLAR DISORDER USING MESENCHYMAL STEM CELLS AND MODIFICATION OF MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 18/470304 [patent_app_country] => US [patent_app_date] => 2023-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18724286 [patent_doc_number] => 20230338420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof [patent_app_type] => utility [patent_app_number] => 18/165244 [patent_app_country] => US [patent_app_date] => 2023-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19599636 [patent_doc_number] => 20240390516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => ADENO-ASSOCIATED VECTORS AND VIRIONS TO TREAT GALACTOSEMIA AND METHODS OF USE AND MANUFACTURE [patent_app_type] => utility [patent_app_number] => 18/688724 [patent_app_country] => US [patent_app_date] => 2022-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18688724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19543420 [patent_doc_number] => 20240360456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => SYNTHETIC RNAS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/681276 [patent_app_country] => US [patent_app_date] => 2022-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21871 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19832612 [patent_doc_number] => 20250084398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => SYSTEMS FOR MODULATING DRUG METABOLISM BY CELLS, METHODS AND COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/294978 [patent_app_country] => US [patent_app_date] => 2022-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19142455 [patent_doc_number] => 20240141294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => CGMP COMPLIANT PRODUCTION AND EXPANSION OF PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM AND PROGENITOR CELLS [patent_app_type] => utility [patent_app_number] => 18/574238 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19345477 [patent_doc_number] => 20240254440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => METHODS TO GENERATE GLIAL RESTRICTED NEURAL PROGENITOR CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/561242 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12300 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19381269 [patent_doc_number] => 20240271139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => Engineered Guide RNAs and Polynucleotides [patent_app_type] => utility [patent_app_number] => 18/568895 [patent_app_country] => US [patent_app_date] => 2022-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -92 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19388031 [patent_doc_number] => 20240277901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => Engineered Neuronal Microtissue Provides Exogenous Axons for Delayed Nerve Fusion and Rapid Neuromuscular Recovery [patent_app_type] => utility [patent_app_number] => 18/568560 [patent_app_country] => US [patent_app_date] => 2022-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17830416 [patent_doc_number] => 20220267720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => FIBROSIS-SPECIFIC CELL CULTURE SUBSTRATE AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/629046 [patent_app_country] => US [patent_app_date] => 2020-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31248 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17807719 [patent_doc_number] => 20220259554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => CELL CULTURE METHOD AND APPLICATION THEREOF BASED ON HIGH-DENSITY AND CONTINUOUS INOCULATION [patent_app_type] => utility [patent_app_number] => 17/627244 [patent_app_country] => US [patent_app_date] => 2020-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627244 [rel_patent_id] =>[rel_patent_doc_number] =>)